cationic polyacrylamide flocculant
-
Technological advancements are reshaping the pharmaceutical intermediate market. Innovations in chemical synthesis, biocatalysis, and continuous manufacturing processes have enhanced the efficiency and sustainability of intermediate production. These advancements enable manufacturers to optimize production yields and reduce waste, thereby lowering costs and minimizing environmental impact.
Clinical studies have investigated the efficacy of pentoxifylline in managing IC. Research has shown that pentoxifylline can significantly improve walking distance and overall functional capacity in patients suffering from claudication. A meta-analysis concluded that patients treated with pentoxifylline experienced notable improvements in their ability to walk compared to those receiving placebo treatment. These improvements are significant as they contribute to enhanced quality of life and mobility for individuals living with this painful condition.
pentoxifylline for intermittent claudication